A pioneer in cancer drug development and interventional oncology, Dr. Jeff Geschwind has dedicated his career to advancing minimally invasive treatment for liver tumors. Through his work with USA Clinics Group, NAMSA, and HistoSonics, he is transforming the landscape of image-guided and tumor-targeted therapies. https://www.konsilmed.com/en/doctor/dr-jean-francois-jeff-geschwind-md